Lise Worthen-Chaudhari
@lisewowdhari.bsky.social
Reposted by Lise Worthen-Chaudhari
A survey showed pts with early-stage #breastcancer placed ⬆️ importance on efficacy and ⬇️ risk of symptomatic adverse events over other attributes when making treatment choices in the adjuvant setting.
pubmed.ncbi.nlm.nih.gov/39915434/
@maryamlustberg.bsky.social @yaleschoolofmed.bsky.social
pubmed.ncbi.nlm.nih.gov/39915434/
@maryamlustberg.bsky.social @yaleschoolofmed.bsky.social
Patient preferences for CDK4/6 inhibitor treatments in HR+/HER2- early breast cancer: a discrete choice survey study - PubMed
This study demonstrated that patients prefer adjuvant treatment with higher efficacy and lower risk of adverse events. These data will aid shared decision-making when discussing the addition of CDK4/6...
pubmed.ncbi.nlm.nih.gov
February 21, 2025 at 1:21 PM
A survey showed pts with early-stage #breastcancer placed ⬆️ importance on efficacy and ⬇️ risk of symptomatic adverse events over other attributes when making treatment choices in the adjuvant setting.
pubmed.ncbi.nlm.nih.gov/39915434/
@maryamlustberg.bsky.social @yaleschoolofmed.bsky.social
pubmed.ncbi.nlm.nih.gov/39915434/
@maryamlustberg.bsky.social @yaleschoolofmed.bsky.social
The Wowdhari kids are doing great…medals for everyone at their last competitions: volleyball for Asha and gymnastics for Casey! 💪🏽👍🏼
January 21, 2025 at 8:54 PM
The Wowdhari kids are doing great…medals for everyone at their last competitions: volleyball for Asha and gymnastics for Casey! 💪🏽👍🏼
Reposted by Lise Worthen-Chaudhari
December 3, 2024 at 6:23 PM